SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-304006
Filing Date
2014-08-11
Accepted
2014-08-11 08:55:24
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT d745458d10q.htm 10-Q 345673
2 2ND AMENDED AND RESTATED AGREEMENT CONCERNING DISABILITY AND DEATH d745458dex101.htm EX-10.1 13414
3 SECTION 302 CEO CERTIFICATION d745458dex311.htm EX-31.1 8270
4 SECTION 302 CFO CERTIFICATION d745458dex312.htm EX-31.2 8296
5 SECTION 906 CEO AND CFO CERTIFICATION d745458dex32.htm EX-32 4059
  Complete submission text file 0001193125-14-304006.txt   2463225

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vivo-20140630.xml EX-101.INS 317590
7 XBRL TAXONOMY EXTENSION SCHEMA vivo-20140630.xsd EX-101.SCH 22662
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vivo-20140630_cal.xml EX-101.CAL 44595
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vivo-20140630_def.xml EX-101.DEF 59667
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20140630_lab.xml EX-101.LAB 200795
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20140630_pre.xml EX-101.PRE 134940
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-14902 | Film No.: 141029049
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences